Cite
HARVARD Citation
Parker Kerrigan, B. et al. (2020). RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine. Neuro-oncology advances. 2 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Parker Kerrigan, B. et al. (2020). RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine. Neuro-oncology advances. 2 (1), p. . [Online].